Rosetta Licenses Resolver to Aventis

Dec 11, 2001

NEW YORK, Dec. 11 - Rosetta Biosoftware said on Tuesday that it has licensed its Rosetta Resolver gene-expression data-analysis system to Aventis Pharmaceuticals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Quidel Q2 Revenues Down 2 Percent
Genomic Vision 1H 2017 Revenues Up 15 Percent
Coimbra Genomics Supporting Portugese Clinical Exome Sequencing Initiative
UPDATE: CRISPR Stakeholders Seek Reversal of Patent Interference Proceeding Decision
Thermo Fisher Scientific Q2 Revenues Up 10 Percent; Firm Increases 2017 Guidance Again
Adaptive Biotechnologies, NCI Collaborate on Immunosequencing Biomarker Discovery

The Scan

Cloud Ready

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

The Science and Policy Connection

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

The New Yeast

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

This Week in Cell

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.

Main menu